These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37263542)

  • 1. Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems.
    Shi M; McHugh KJ
    Adv Drug Deliv Rev; 2023 Aug; 199():114904. PubMed ID: 37263542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.
    Mandal A; Pal D; Agrahari V; Trinh HM; Joseph M; Mitra AK
    Adv Drug Deliv Rev; 2018 Feb; 126():67-95. PubMed ID: 29339145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
    Fogueri LR; Singh S
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches.
    Kashani GK; Naghib SM; Soleymani S; Mozafari MR
    Int J Biol Macromol; 2024 May; 268(Pt 1):131694. PubMed ID: 38642693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.
    Phyo P; Zhao X; Templeton AC; Xu W; Cheung JK; Su Y
    Adv Drug Deliv Rev; 2021 Jul; 174():1-29. PubMed ID: 33609600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
    Christophersen PC; Fano M; Saaby L; Yang M; Nielsen HM; Mu H
    Curr Pharm Des; 2015; 21(19):2611-28. PubMed ID: 25876916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery of peptides and proteins.
    Degim IT; Celebi N
    Curr Pharm Des; 2007; 13(1):99-117. PubMed ID: 17266590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier Mediated Systemic Delivery of Protein and Peptide Therapeutics.
    Zaman R; Othman I; Chowdhury EH
    Curr Pharm Des; 2016; 22(40):6167-6191. PubMed ID: 27510479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive delivery strategies for biologics.
    Anselmo AC; Gokarn Y; Mitragotri S
    Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel non-invasive protein and peptide drug delivery approaches.
    Wallis L; Kleynhans E; Toit TD; Gouws C; Steyn D; Steenekamp J; Viljoen J; Hamman J
    Protein Pept Lett; 2014; 21(11):1087-101. PubMed ID: 25106909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation strategies for sustained release of proteins.
    Lewis AL; Illum L
    Ther Deliv; 2010 Sep; 1(3):457-79. PubMed ID: 22816145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs.
    Ye Q; Asherman J; Stevenson M; Brownson E; Katre NV
    J Control Release; 2000 Feb; 64(1-3):155-66. PubMed ID: 10640654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.
    Agrahari V; Agrahari V; Mitra AK
    Ther Deliv; 2016; 7(4):257-78. PubMed ID: 27010987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamental advances in hydrogels for the development of the next generation of smart delivery systems as biopharmaceuticals.
    Nassar N; Kasapis S
    Int J Pharm; 2023 Feb; 633():122634. PubMed ID: 36690133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms.
    Houchin ML; Topp EM
    J Pharm Sci; 2008 Jul; 97(7):2395-404. PubMed ID: 17828756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel delivery systems for improving the clinical use of peptides.
    Kovalainen M; Mönkäre J; Riikonen J; Pesonen U; Vlasova M; Salonen J; Lehto VP; Järvinen K; Herzig KH
    Pharmacol Rev; 2015 Jul; 67(3):541-61. PubMed ID: 26023145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advance in Polymer Based Microspheric Systems for Controlled Protein and Peptide Delivery.
    Yang Y; Chen Q; Lin J; Cai Z; Liao G; Wang K; Bai L; Zhao P; Yu Z
    Curr Med Chem; 2019; 26(13):2285-2296. PubMed ID: 30963961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide gels for controlled release of proteins.
    Uzunalli G; Guler MO
    Ther Deliv; 2020 Mar; 11(3):193-211. PubMed ID: 32238023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.